As of 2025-07-12, the Intrinsic Value of Immunic Inc (IMUX) is -5.03 USD. This IMUX valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.83 USD, the upside of Immunic Inc is -705.96%.
Based on its market price of 0.83 USD and our intrinsic valuation, Immunic Inc (IMUX) is overvalued by 705.96%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -5.03 - -5.03 | -5.03 | -705.96% |
| P/E | (22.62) - (12.82) | (17.05) | -2154.2% |
| DDM - Stable | (6.15) - (25.20) | (15.68) | -1988.8% |
| DDM - Multi | (2.01) - (6.87) | (3.16) | -481.1% |
| Market Cap (mil) | 79.54 |
| Beta | 1.08 |
| Outstanding shares (mil) | 95.82 |
| Enterprise Value (mil) | 65.24 |
| Market risk premium | 4.60% |
| Cost of Equity | 11.60% |
| Cost of Debt | 5.00% |
| WACC | 7.63% |